½ÃÀ庸°í¼­
»óǰÄÚµå
1463020

ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦°øº°, ¼öÁغ°, Àü°³º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)

Healthcare Interoperability Solutions Market Share, Size, Trends, Industry Analysis Report, By Offering (Solutions, Services); By Level; By Deployment; By End User; By Region; Segment Forecast, 2024- 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 117 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠ¿¬±¸¿¡ µû¸£¸é, ¼¼°è ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 115¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ȯÀÚ Á᫐ Áø·á¿¡ ´ëÇÑ °ü½ÉÀÌ ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀåÀ» Á¡Á¡ ´õ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀº ȯÀÚ Áß½ÉÀÇ Á¢±Ù ¹æ½ÄÀ¸·Î ÁøÈ­Çϰí ÀÖÀ¸¸ç, Ä¡·á Á¶Á¤ ¹× Âü¿© °­È­¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. »óÈ£¿î¿ë¼º ¼Ö·ç¼ÇÀº ´Ù¾çÇÑ ÀÇ·á ½Ã½ºÅÛ°ú ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ ¿øÈ°ÇÑ µ¥ÀÌÅÍ ±³È¯À» ÃËÁøÇϰí ȯÀÚÀÇ ÀÇ·á ±â·Ï¿¡ ´ëÇÑ Á¢±Ù°ú ¾÷µ¥ÀÌÆ®¸¦ º¸ÀåÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ´Ù¾çÇÑ ÃâóÀÇ È¯ÀÚ µ¥ÀÌÅ͸¦ Áý°èÇϰí ÅëÇÕÇÔÀ¸·Î½á ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô º¸´Ù °³ÀÎÈ­µÇ°í Á¶Á¤µÈ Ä¡·á °æÇèÀ» Á¦°øÇÒ ¼ö ÀÖ´Â ¿ª·®À» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, »óÈ£¿î¿ë¼ºÀº °Ç°­ Á¤º¸¿¡ ´ëÇÑ Á¢±Ù°ú °øÀ¯¸¦ °¡´ÉÇÏ°Ô Çϰí, ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ Çù·ÂÀ» ÃËÁøÇÏ¿© ȯÀÚÀÇ ÆäÀ̽¼Æ® ¿©Á¤¿¡ ´ëÇÑ Âü¿©¸¦ Áö¿øÇÕ´Ï´Ù.

¿ø°ÝÀÇ·á¿Í ¿ø°Ý ¸ð´ÏÅ͸µÀÇ ±Þ¼ÓÇÑ È®´ë´Â ƯÈ÷ COVID-19 ÆÒµ¥¹Í ±â°£ µ¿¾È Àα⸦ ²ø¾úÀ¸¸ç, ¹°¸®Àû Á¢ÃËÀ» ÃÖ¼ÒÈ­Çϸ鼭 Æí¸®ÇÑ ÀÇ·á ¼­ºñ½º Á¢±ÙÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, ¿þ¾î·¯ºí ¼¾¼­¿Í °°Àº ¿ø°Ý ¸ð´ÏÅ͸µ Àåºñ´Â ½Ç½Ã°£À¸·Î ȯÀÚ µ¥ÀÌÅ͸¦ ¼öÁýÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ¿ø°ÝÀÇ·á¿Í ¿ø°Ý ¸ð´ÏÅ͸µÀ» ÃæºÐÈ÷ Ȱ¿ëÇϱâ À§Çؼ­´Â »óÈ£¿î¿ë¼º ¼Ö·ç¼ÇÀÌ ÇʼöÀûÀÔ´Ï´Ù. ´Ù¾çÇÑ Ç÷§Æû, ÀüÀÚ ÀÇ·á ±â·Ï, ÀÇ·á±â±â °£ÀÇ µ¥ÀÌÅ͸¦ ¿øÈ°ÇÏ°Ô ÅëÇÕÇÏ¿© Á¾ÇÕÀûÀΠȯÀÚ Á¤º¸¿¡ ´ëÇÑ ¾×¼¼½º¸¦ º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, »óÈ£¿î¿ë¼ºÀº ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ Áø·á Á¶Á¤ ¹× Ä¿¹Â´ÏÄÉÀ̼ÇÀ» °­È­ÇÏ¿© °á°ú¸¦ °³¼±ÇÏ°í ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Á¤¹ÐÀÇ·á¿Í À¯Àüü µ¥ÀÌÅÍ ±³È¯ Áö¿øÀº ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. Á¤¹ÐÀÇ·á´Â °³ÀÎÀÇ À¯ÀüÀû, »ýȰ½À°ü, ȯ°æÀû ¿äÀο¡ µû¶ó Ä¡·á¸¦ Á¶Á¤ÇÏ´Â °ÍÀ¸·Î, À¯Àüü µ¥ÀÌÅÍ¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª °Ô³ð µ¥ÀÌÅÍ´Â º¹ÀâÇÏ°í ¾çÀÌ ¸¹±â ¶§¹®¿¡ »óÈ£¿î¿ë¼º ¹®Á¦°¡ ¹ß»ýÇÕ´Ï´Ù. »óÈ£¿î¿ë¼º ¼Ö·ç¼ÇÀº ÇコÄÉ¾î ½Ã½ºÅÛ ¹× ¿¬±¸ Ç÷§Æû °£ÀÇ ¿øÈ°ÇÑ °Ô³ð µ¥ÀÌÅÍ ±³È¯ ¹× ÅëÇÕÀ» ÃËÁøÇÏ¿© ÀÌ·¯ÇÑ Àå¾Ö¹°À» ÇØ°áÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº °Ô³ð Á¤º¸¿¡ ½±°Ô Á¢±ÙÇÏ°í °øÀ¯ÇÒ ¼ö ÀÖµµ·ÏÇÔÀ¸·Î½á ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô °³ÀÎ ¸ÂÃãÇü ÀǷḦ Á¦°øÇÒ ¼ö ÀÖ´Â ¿ª·®À» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ¿¬±¸ÀÚ, ÀÓ»óÀÇ, ÀÌÇØ°ü°èÀÚ °£ÀÇ Çù¾÷À» ÃËÁøÇÏ¿© Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ³ë·ÂÀ» ÃËÁøÇÕ´Ï´Ù.

°øÁߺ¸°Ç ¸ð´ÏÅ͸µ ¹× º¸°íÀÇ »óÈ£¿î¿ë¼ºÀÌ ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. È¿À²ÀûÀÎ µ¥ÀÌÅÍ ±³È¯Àº Áúº´ ¸ð´ÏÅ͸µ°ú ¹ßº´ ŽÁö¿¡ ÇʼöÀûÀÔ´Ï´Ù. »óÈ£¿î¿ë¼º ¼Ö·ç¼ÇÀº °øÁߺ¸°Ç ½Ã½ºÅÛ, ÀÇ·á ½Ã¼³ ¹× Á¤ºÎ ±â°ü °£ÀÇ ¿øÈ°ÇÑ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» ÃËÁøÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ȯÀÚ Æ¯¼º ¹× °Ë»ç °á°ú¿Í °°Àº ¿ªÇÐ µ¥ÀÌÅ͸¦ ±³È¯ÇÒ ¼ö ÀÖ°ÔÇÔÀ¸·Î½á °¨½Ã ¿ª·®À» °­È­Çϰí Áúº´ Ãß¼¼¸¦ Àû½Ã¿¡ ÆÄ¾ÇÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ, »óÈ£¿î¿ë¼ºÀ» ÅëÇØ º¸°í ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ°í °øÁߺ¸°Ç ´ç±¹¿¡ ´ëÇÑ µ¥ÀÌÅÍ Á¦ÃâÀ» Ç¥ÁØÈ­ ¹× ÀÚµ¿È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¤ºÎ°¡ °øÁߺ¸°Ç ÀÎÇÁ¶ó¿¡ ´ëÇÑ ¿ì¼±¼øÀ§¸¦ ºÎ¿©ÇÔ¿¡ µû¶ó °øÁߺ¸°ÇÀ» À§ÇØ Á¶Á¤µÈ »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ½ÃÀå È®´ë¿¡ Å« ±âȸ°¡ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

2023³â¿¡´Â ÄÁ¼³ÆÃ ¹× ÀÚ¹® ¼­ºñ½º, µ¥ÀÌÅÍ ¸¶À̱׷¹ÀÌ¼Ç ¹× ÅëÇÕ ¼­ºñ½º, ±¸Çö Áö¿ø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¼­ºñ½º ºÎ¹®ÀÌ Å« ¸ÅÃâ ºñÁßÀ» Â÷ÁöÇß½À´Ï´Ù.

2023³â¿¡´Â ÀÇ·á ½Ã½ºÅÛÀÇ º¹À⼺, Ç¥ÁØÈ­ ¿ä±¸ »çÇ×, ½ÅÈï ±â¼ú°úÀÇ ÅëÇÕÀ¸·Î ÀÎÇØ ±¸Á¶ ºÎ¹®ÀÌ Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®Àº ºñ¿ë È¿À²¼º, È®À强 ¹× À¯¿¬¼º, Á¢±Ù¼º ¹× ¿ø°Ý Çù¾÷À¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2023³â ÀÇ·á ¼­ºñ½º Á¦°øÀÚ ºÎ¹®Àº ȯÀÚ µ¥ÀÌÅÍ¿¡ ´ëÇÑ Á÷Á¢ Âü¿©, ÀÓ»ó ¿öÅ©Ç÷οì ÅëÇÕ, ±ÔÁ¦ Áؼö ¿ä±¸ »çÇ×À¸·Î ÀÎÇØ Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

2023³â ºÏ¹Ì°¡ ³ôÀº ¼öÁØÀÇ ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº ÀüÀÚ ÀÇ·á ±â·Ï º¸±Þ·ü, Á¤ºÎÀÇ ³ë·ÂÀ¸·Î ÀÎÇØ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÀÌ ½ÃÀåÀº Cerner Corporation, Epic Systems Corporation, GE Healthcare, InterSystems Corporation, Meditech, NextGen Healthcare, Inc, Philips Healthcare µî ¼¼°èÀûÀÎ ½ÃÀå ±â¾÷µéÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ °æÀïÀÌ Ä¡¿­ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå ÀλçÀÌÆ®

  • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç - ¾÷°è ÇöȲ
  • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê³ª Àǹ«È­¿¡ ÀÇÇØ Á¦Ç° ¼ö¿ä°¡ ÀÚ±ØµÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
      • ÀüÀڰǰ­±â·Ï µµÀÔ È®´ë
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
      • µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿Í º¸¾È¿¡ °üÇÑ ¿ì·Á
  • PESTLE ºÐ¼®
  • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ¾÷°è µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå Á¦°øº° ¼¼°è ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¼Ö·ç¼Ç
  • ¼­ºñ½º

Á¦6Àå ¼öÁغ° ¼¼°è ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ±¸Á¶Àû
  • ÀǹÌÀû
  • ±âÃÊÀû

Á¦7Àå ÃÖÁ¾»ç¿ëÀÚº° ¼¼°è ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ÇコÄɾî Á¦°øÀÚ
  • ÇコÄɾî ÁöºÒÀÚ
  • ¾à±¹
  • ±âŸ

Á¦8Àå Àü°³º° ¼¼°è ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¿ÂÇÁ·¹¹Ì½º
  • Ŭ¶ó¿ìµå ±â¹Ý

Á¦9Àå Áö¿ªº° ¼¼°è ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå Æò°¡, Áö¿ª,2019-2032
  • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Á¦°øº°, 2019-2032³â
    • ºÏ¹Ì : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Àü°³º°, 2019-2032³â
    • ºÏ¹Ì : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ·¹º§º°, 2019-2032³â
    • ºÏ¹Ì : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ¹Ì±¹
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ij³ª´Ù
  • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - À¯·´
    • À¯·´ : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Á¦°øº°, 2019-2032³â
    • À¯·´ : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Àü°³º°, 2019-2032³â
    • À¯·´ : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ·¹º§º°,2019-2032
    • À¯·´ : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ¿µ±¹
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ÇÁ¶û½º
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - µ¶ÀÏ
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ÀÌÅ»¸®¾Æ
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ½ºÆäÀÎ
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ³×µ¨¶õµå
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ·¯½Ã¾Æ
  • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Á¦°øº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Àü°³º°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ·¹º§º°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - Áß±¹
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - Àεµ
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ÀϺ»
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ¸»·¹À̽þÆ
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - Àεµ³×½Ã¾Æ
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - Çѱ¹
  • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Á¦°øº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Àü°³º°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ·¹º§º°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - À̽º¶ó¿¤
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - UAE
  • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Á¦°øº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, Àü°³º°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ·¹º§º°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ¸ß½ÃÄÚ
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ºê¶óÁú
    • ÇコÄÉ¾î »óÈ£¿î¿ë¼º ¼Ö·ç¼Ç ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦10Àå °æÀï »óȲ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • ÆÄÆ®³Ê½Ê/Çù¾÷/°è¾à/Àü½Ãȸ

Á¦11Àå ±â¾÷ °³¿ä

  • Allscripts Healthcare Solutions, Inc.
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Cerner Corporation
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Change Healthcare
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Epic Systems Corporation
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • GE Healthcare
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • InterSystems Corporation
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Jitterbit
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Koch Industries, Inc
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Meditech
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • NextGen Healthcare, Inc.
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Orion Health
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • OSP Labs
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Philips Healthcare
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Veradigm Inc.
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
  • Virtusa Corpopration
    • ±â¾÷ °³¿ä
    • À繫 ½ÇÀû
    • Á¦Ç° º¥Ä¡¸¶Å©
    • ÃÖ±ÙÀÇ °³¹ß
ksm 24.05.14

The global healthcare interoperability solutions market size is expected to reach USD 11.52 billion by 2032, according to a new study by Polaris Market Research. The report "Healthcare Interoperability Solutions Market Share, Size, Trends, Industry Analysis Report, By Offering (Solutions, Services); By Level; By Deployment; By End User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A focus on patient-centered care increasingly drives the healthcare interoperability solutions market. With healthcare delivery evolving towards patient-centric approaches, there's a heightened emphasis on enhancing care coordination and engagement. Interoperability solutions play a pivotal role by facilitating seamless data exchange between diverse healthcare systems and providers, ensuring patients' medical records are readily accessible and updated. By aggregating and integrating patient data from various sources, these solutions empower providers to deliver more personalized and coordinated care experiences. Moreover, interoperability supports patient involvement in their healthcare journey by enabling access to and sharing of health information, fostering collaboration between patients and providers.

The rapid expansion of telehealth and remote monitoring, particularly popular during the COVID-19 pandemic, offer convenient healthcare access while minimizing physical contact. Additionally, remote monitoring devices like wearable sensors enable real-time patient data collection. However, to fully leverage telehealth and remote monitoring, interoperability solutions are vital. They seamlessly integrate data between various platforms, electronic health records, and medical devices, ensuring comprehensive patient information accessibility. Interoperability also enhances care coordination and communication among healthcare providers, improving outcomes and reducing costs.

Support for precision medicine and genomic data exchange is creating lucrative opportunities in the healthcare interoperability solutions market. Precision medicine tailors treatments based on an individual's genetic, lifestyle, and environmental factors, relying heavily on genomic data. However, interoperability challenges arise due to the complexity and volume of genomic data. Interoperability solutions address these hurdles by facilitating seamless exchange and integration of genomic data across healthcare systems and research platforms. By enabling easy access and sharing of genomic information, these solutions empower providers to deliver personalized care. They also foster collaboration among researchers, clinicians, and stakeholders, driving advancements in precision medicine initiatives.

Interoperability in public health surveillance and reporting is driving further growth in the healthcare interoperability solutions market. Efficient data exchange is critical for disease monitoring and outbreak detection. Interoperability solutions facilitate seamless communication among public health systems, healthcare facilities, and government agencies. By enabling the exchange of epidemiological data, such as patient demographics and laboratory results, these solutions enhance surveillance capabilities and enable the timely identification of disease trends. Moreover, interoperability streamlines reporting processes, standardizing and automating data submission to public health authorities. With governments prioritizing public health infrastructure, the demand for interoperability solutions tailored for public health is set to increase, presenting significant opportunities for market expansion.

Healthcare Interoperability Solutions Market Report Highlights

In 2023, the services segment held significant revenue share owing to greater demand for consulting and advisory services, data migration and integration services, and implementation support.

In 2023, the structural segment held significant revenue share owing to complexity of healthcare systems, standardization requirements, and integration with emerging technologies.

The cloud-based segment is expected to experience significant growth during the forecast period owing to cost-effectiveness, scalability and flexibility, and accessibility and remote collaboration.

In 2023, the healthcare providers segment held significant revenue share owing to direct engagement with patient data, clinical workflow integration, and regulatory compliance requirements.

In 2023, North America region accounted for a significant market share due to advanced healthcare infrastructure, high adoption of electronic health records, and government initiatives.

The market is highly competitive owing to the existence of market players with a global presence, including Cerner Corporation, Epic Systems Corporation, GE Healthcare, InterSystems Corporation, Meditech, NextGen Healthcare, Inc., Orion Health, and Philips Healthcare among others.

Polaris Market Research has segmented the Healthcare Interoperability Solutions market report based on offering, level, deployment, end user, and region:

Healthcare Interoperability Solutions, Offering Outlook (Revenue - USD Billion, 2019 - 2032)

  • Solutions
  • Services

Healthcare Interoperability Solutions, Level Outlook (Revenue - USD Billion, 2019 - 2032)

  • Structural
  • Semantic
  • Foundational

Healthcare Interoperability Solutions, Deployment Outlook (Revenue - USD Billion, 2019 - 2032)

  • On-premise
  • Cloud Based

Healthcare Interoperability Solutions, End User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Healthcare Providers
  • Healthcare Payers
  • Pharmacies
  • Others

Healthcare Interoperability Solutions, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Healthcare Interoperability Solutions Market Insights

  • 4.1. Healthcare Interoperability Solutions - Industry Snapshot
  • 4.2. Healthcare Interoperability Solutions Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Government initiatives and mandates are projected to spur the product demand
      • 4.2.1.2. Growing adoption of electronic health records
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data privacy and security concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Healthcare Interoperability Solutions Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Healthcare Interoperability Solutions Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
  • 5.3. Solutions
    • 5.3.1. Global Healthcare Interoperability Solutions Market, by Solutions, by Region, 2019-2032 (USD Billion)
  • 5.4. Services
    • 5.4.1. Global Healthcare Interoperability Solutions Market, by Services, by Region, 2019-2032 (USD Billion)

6. Global Healthcare Interoperability Solutions Market, by Level

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
  • 6.3. Structural
    • 6.3.1. Global Healthcare Interoperability Solutions Market, by Structural, by Region, 2019-2032 (USD Billion)
  • 6.4. Semantic
    • 6.4.1. Global Healthcare Interoperability Solutions Market, by Semantic, by Region, 2019-2032 (USD Billion)
  • 6.5. Foundational
    • 6.5.1. Global Healthcare Interoperability Solutions Market, by Foundational, by Region, 2019-2032 (USD Billion)

7. Global Healthcare Interoperability Solutions Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
  • 7.3. Healthcare Providers
    • 7.3.1. Global Healthcare Interoperability Solutions Market, by Healthcare Providers, by Region, 2019-2032 (USD Billion)
  • 7.4. Healthcare Payers
    • 7.4.1. Global Healthcare Interoperability Solutions Market, by Healthcare Payers, by Region, 2019-2032 (USD Billion)
  • 7.5. Pharmacies
    • 7.5.1. Global Healthcare Interoperability Solutions Market, by Pharmacies, by Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Healthcare Interoperability Solutions Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Healthcare Interoperability Solutions Market, by Deployment

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
  • 8.3. On-premise
    • 8.3.1. Global Healthcare Interoperability Solutions Market, by On-premises, by Region, 2019-2032 (USD Billion)
  • 8.4. Cloud-based
    • 8.4.1. Global Healthcare Interoperability Solutions Market, by Cloud-based, by Region, 2019-2032 (USD Billion)

9. Global Healthcare Interoperability Solutions Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Healthcare Interoperability Solutions Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Healthcare Interoperability Solutions Market - North America
    • 9.3.1. North America: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
    • 9.3.2. North America: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
    • 9.3.3. North America: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
    • 9.3.4. North America: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.3.5. Healthcare Interoperability Solutions Market - U.S.
      • 9.3.5.1. U.S.: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.3.6. Healthcare Interoperability Solutions Market - Canada
      • 9.3.6.1. Canada: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
  • 9.4. Healthcare Interoperability Solutions Market - Europe
    • 9.4.1. Europe: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.4.5. Healthcare Interoperability Solutions Market - UK
      • 9.4.5.1. UK: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.4.6. Healthcare Interoperability Solutions Market - France
      • 9.4.6.1. France: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.4.7. Healthcare Interoperability Solutions Market - Germany
      • 9.4.7.1. Germany: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.4.8. Healthcare Interoperability Solutions Market - Italy
      • 9.4.8.1. Italy: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.4.9. Healthcare Interoperability Solutions Market - Spain
      • 9.4.9.1. Spain: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.4.10. Healthcare Interoperability Solutions Market - Netherlands
      • 9.4.10.1. Netherlands: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.4.11. Healthcare Interoperability Solutions Market - Russia
      • 9.4.11.1. Russia: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
  • 9.5. Healthcare Interoperability Solutions Market - Asia Pacific
    • 9.5.1. Asia Pacific: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.5.5. Healthcare Interoperability Solutions Market - China
      • 9.5.5.1. China: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.5.6. Healthcare Interoperability Solutions Market - India
      • 9.5.6.1. India: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.5.7. Healthcare Interoperability Solutions Market - Japan
      • 9.5.7.1. Japan: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.5.8. Healthcare Interoperability Solutions Market - Malaysia
      • 9.5.8.1. Malaysia: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.5.9. Healthcare Interoperability Solutions Market - Indonesia
      • 9.5.9.1. Indonesia: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.5.10. Healthcare Interoperability Solutions Market - South Korea
      • 9.5.10.1. South Korea: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
  • 9.6. Healthcare Interoperability Solutions Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.6.5. Healthcare Interoperability Solutions Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.6.6. Healthcare Interoperability Solutions Market - South Africa
      • 9.6.6.1. South Africa: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.6.7. Healthcare Interoperability Solutions Market - Israel
      • 9.6.7.1. Israel: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.6.8. Healthcare Interoperability Solutions Market - UAE
      • 9.6.8.1. UAE: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
  • 9.7. Healthcare Interoperability Solutions Market - Latin America
    • 9.7.1. Latin America: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.7.5. Healthcare Interoperability Solutions Market - Mexico
      • 9.7.5.1. Mexico: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.7.6. Healthcare Interoperability Solutions Market - Brazil
      • 9.7.6.1. Brazil: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)
    • 9.7.7. Healthcare Interoperability Solutions Market - Argentina
      • 9.7.7.1. Argentina: Healthcare Interoperability Solutions Market, by Offering, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Healthcare Interoperability Solutions Market, by Deployment, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Healthcare Interoperability Solutions Market, by Level, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Healthcare Interoperability Solutions Market, by End User, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Proflies

  • 11.1. Allscripts Healthcare Solutions, Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Cerner Corporation
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Change Healthcare
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Epic Systems Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. GE Healthcare
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. InterSystems Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Jitterbit
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Koch Industries, Inc
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Meditech
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. NextGen Healthcare, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Orion Health
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. OSP Labs
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Philips Healthcare
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Veradigm Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Virtusa Corpopration
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦